Division of Vascular Surgery, Columbia University and NewYork-Presbyterian Hospital, New York, NY, USA.
J Vasc Surg. 2010 May;51(5):1081-7. doi: 10.1016/j.jvs.2009.10.113. Epub 2010 Mar 20.
Although repair of large abdominal aortic aneurysms (AAAs) is well accepted, randomized clinical trials have failed to demonstrate benefit for early surgical repair of small aneurysms compared with surveillance. Endovascular repair has been shown to be safer than open surgical repair in patients with large aneurysms, prompting a randomized trial of early endovascular repair vs surveillance in patients with small aneurysms.
We randomly assigned 728 patients (13.3% women; mean age, 71 +/- 8 years) with 4 to 5 cm AAAs to early endovascular repair (366 patients) or ultrasound surveillance (362 patients). Rupture or aneurysm-related death and overall mortality in the two groups were compared during a mean follow-up of 20 +/- 12 months.
Among patients randomized to treatment, 89% underwent aneurysm repair. Among patients randomized to surveillance, 31% underwent aneurysm repair during the course of the study. After a mean follow-up of 20 +/- 12 months (range, 0-41 months), 15 deaths had occurred in each group (4.1%). The unadjusted hazard ratio (95% confidence interval) for mortality after early endovascular repair was 1.01 (0.49-2.07, P = .98). Aneurysm rupture or aneurysm-related death occurred in two patients in each group (0.6%). The unadjusted hazard ratio was 0.99 (0.14-7.06, P = .99) for early endovascular repair.
Early treatment with endovascular repair and rigorous surveillance with selective aneurysm treatment as indicated both appear to be safe alternatives for patients with small AAAs, protecting the patient from rupture or aneurysm-related death for at least 3 years.
尽管修复大型腹主动脉瘤(AAA)已被广泛接受,但随机临床试验未能证明与监测相比,早期手术修复小型动脉瘤具有优势。血管内修复在大型动脉瘤患者中已被证明比开放手术修复更安全,这促使对小型动脉瘤患者进行早期血管内修复与监测的随机试验。
我们随机分配了 728 名(13.3%为女性;平均年龄 71+/-8 岁)4-5cm 的 AAA 患者进行早期血管内修复(366 名患者)或超声监测(362 名患者)。在平均 20+/-12 个月的随访期间,比较两组患者的破裂或动脉瘤相关死亡和总死亡率。
在接受治疗的随机分组患者中,89%接受了动脉瘤修复。在接受监测的随机分组患者中,31%在研究过程中进行了动脉瘤修复。在平均 20+/-12 个月(范围 0-41 个月)的随访后,每组各有 15 例死亡(4.1%)。早期血管内修复后的死亡率未调整危险比(95%置信区间)为 1.01(0.49-2.07,P=0.98)。两组各有 2 例患者发生动脉瘤破裂或动脉瘤相关死亡(0.6%)。未调整的危险比为 0.99(0.14-7.06,P=0.99)。
早期血管内修复治疗和严格监测并选择性治疗动脉瘤,对于小型 AAA 患者而言,这两种方法似乎都是安全的选择,可以至少 3 年内保护患者免受破裂或动脉瘤相关死亡的风险。